AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36394733 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin photosensitizer (CP) + MTAD
Number of subjects: 40
Study 36394733 — intervention group
Group type: COMPARATOR
Intervention: 2.25% NaOCl + MTAD
Number of subjects: 40
Study 33676727 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled methoxyflurane 3 ml
Number of subjects: 12
Study 33676727 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 25 μg i.v.
Number of subjects: 12
Study 33676727 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 50 μg i.v.
Number of subjects: 12
Study 33676727 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 12
Study 34698342 — intervention group
Group type: EXPERIMENTAL
Intervention: Free distribution of oral rehydration salts (ORS) via home deliveries prior to diarrhea onset
Number of subjects: 0
Study 34698342 — intervention group
Group type: EXPERIMENTAL
Intervention: Free distribution of ORS via vouchers
Number of subjects: 0
Study 34698342 — intervention group
Group type: EXPERIMENTAL
Intervention: Door-to-door sales model (home sales)
Number of subjects: 0
Study 34698342 — intervention group
Group type: COMPARATOR
Intervention: Control arm (normal activities of CHWs)
Number of subjects: 0
Study 35385542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 using both mobile platform and MCH
Number of subjects: 3002
Study 35385542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2 using MCH alone
Number of subjects: 3002
Study 35385542 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3002
Study 35385542 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal mortality rate with CoC
Number of subjects: 3002
Study 35385542 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal mortality rate without CoC
Number of subjects: 3002
Study 33452340 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (HF-rTMS)
Number of subjects: 40
Study 33452340 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 40
Study 32045441 — intervention group
Group type: EXPERIMENTAL
Intervention: Alanine transaminase (ALT)
Number of subjects: 3455
Study 32045441 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP)
Number of subjects: 3455
Study 32045441 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) estimates for ALT
Number of subjects: 3455
Study 32045441 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP) and gamma glutamyltransferase (GGT)
Number of subjects: 3455
Study 36138388 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled local anesthesia (CCLA)
Number of subjects: 60
Study 36138388 — intervention group
Group type: COMPARATOR
Intervention: Conventional local anesthesia (LA)
Number of subjects: 60
Study 32586428 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Treatment for Insomnia (BBTI)
Number of subjects: 63
Study 32586428 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy for Insomnia (CBTI)
Number of subjects: 63
Study 33550193 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosemary essential oil inhalation (1 drop using a mask)
Number of subjects: 80
Study 33550193 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control group)
Number of subjects: 80
Study 35468032 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: misoprostol 400 mcg vaginally and pyridoxine 40 mg sublingually
Number of subjects: 140
Study 35468032 — intervention group
Group type: COMPARATOR
Intervention: Group B: misoprostol 400 mcg sublingually and pyridoxine 40 mg vaginally
Number of subjects: 140
Study 35468032 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 140
Study 32857643 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion guide
Number of subjects: 100
Study 32857643 — intervention group
Group type: COMPARATOR
Intervention: Standard education material
Number of subjects: 100
Study 33220066 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose flumazenil (20 µg/kg)
Number of subjects: 6
Study 33220066 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose flumazenil (10 µg/kg)
Number of subjects: 6
Study 33220066 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study 35340231 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 laser shots
Number of subjects: 55
Study 35340231 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 laser shots
Number of subjects: 55
Study 35340231 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 laser shots
Number of subjects: 55
Study 34543864 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib with carboplatin and pemetrexed
Number of subjects: 30
Study 34543864 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib with cisplatin and pemetrexed
Number of subjects: 30
Study 33529081 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM5 treatment (5 g lemongrass/ewe/d)
Number of subjects: 30
Study 33529081 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM10 treatment (10 g lemongrass/ewe/d)
Number of subjects: 30
Study 33529081 — intervention group
Group type: COMPARATOR
Intervention: Control (without supplement)
Number of subjects: 30
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental illness (schizophrenia)
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental illness (alcohol dependency)
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental illness (depression)
Number of subjects: 290
Study 32208898 — intervention group
Group type: COMPARATOR
Intervention: Control (no mental illness)
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of mental illness (MI)
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of mental illness
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiarity with MI and criminality
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived race of the person
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived MI severity
Number of subjects: 290
Study 32208898 — intervention group
Group type: EXPERIMENTAL
Intervention: Likelihood of rehabilitation
Number of subjects: 290
Study 36270197 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted motivational interviewing (CAMI)
Number of subjects: 0
Study 36270197 — intervention group
Group type: COMPARATOR
Intervention: Unadapted motivational interviewing (MI)
Number of subjects: 0
Study 33531693 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted intraoperative radiotherapy (TARGIT‐IORT) during lumpectomy
Number of subjects: 0
Study 33531693 — intervention group
Group type: COMPARATOR
Intervention: Whole-breast external beam radiotherapy
Number of subjects: 0
Study 33531693 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 0
Study 35080713 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention for cannabis use disorder
Number of subjects: 47
Study 34012064 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg/day)
Number of subjects: 88
Study 34012064 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg/day)
Number of subjects: 88
Study 34012064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 34012064 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide vs Placebo
Number of subjects: 88
Study 34012064 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin vs Placebo
Number of subjects: 88
Study 34848381 — intervention group
Group type: EXPERIMENTAL
Intervention: VP250 (250‐μg peanut protein)
Number of subjects: 393
Study 34848381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study 34848381 — intervention group
Group type: EXPERIMENTAL
Intervention: VP250
Number of subjects: 393
Study 34974573 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 60
Study 34974573 — intervention group
Group type: COMPARATOR
Intervention: Milligan Morgan technique
Number of subjects: 60
Study 35193872 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0
Study 35193872 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study 35193872 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg plus MTX
Number of subjects: 0
Study 35193872 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study 32400190 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully-matched message frame condition
Number of subjects: 147
Study 32400190 — intervention group
Group type: EXPERIMENTAL
Intervention: Valence-matched message frame condition
Number of subjects: 147
Study 32400190 — intervention group
Group type: COMPARATOR
Intervention: Unmatched message frame condition
Number of subjects: 147
Study 33917987 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency protein-rich meal service (six protein-rich dishes per day)
Number of subjects: 102
Study 34032906 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 60
Study 34032906 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 60
Study 34511891 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol (5 μg/5 μg)
Number of subjects: 213
Study 34511891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study 35958815 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention group
Number of subjects: 100
Study 35958815 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention group
Number of subjects: 100
Study 35958815 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports nutrition intervention group
Number of subjects: 100
Study 35958815 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 32659982 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast consumption groups (BCG)
Number of subjects: 671
Study 32659982 — intervention group
Group type: EXPERIMENTAL
Intervention: Skipping breakfast
Number of subjects: 671
Study 35007188 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination (BCG-Denmark, BCG-Japan, BCG-Russia)
Number of subjects: 214
Study 34189981 — intervention group
Group type: EXPERIMENTAL
Intervention: B12 fortified nutrient bar (2 μg)
Number of subjects: 282
Study 34189981 — intervention group
Group type: EXPERIMENTAL
Intervention: B12 fortified yogurt (2 μg)
Number of subjects: 282
Study 34189981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 34189981 — intervention group
Group type: COMPARATOR
Intervention: Propionibacterium (1 × 10^8 cfu/g)
Number of subjects: 282
Study 34189981 — intervention group
Group type: EXPERIMENTAL
Intervention: B12 supplementation (in both trials)
Number of subjects: 282
Study 34189981 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometry and hemoglobin measurements
Number of subjects: 282
Study 36169579 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Talk Intervention (FTI)
Number of subjects: 89
Study 36169579 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Talk about Children (LTC)
Number of subjects: 89
Study 36169579 — intervention group
Group type: COMPARATOR
Intervention: Interventions as Usual (IAU)
Number of subjects: 89
Study 33427870 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral moxifloxacin (400 mg/d for 7 days)
Number of subjects: 599
Study 33427870 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ertapenem (1 g/d for 2 days) followed by oral levofloxacin (500 mg/d) and metronidazole (500 mg 3 times/d for 5 days)
Number of subjects: 599
Study 32434490 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 158
Study 34006174 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing meditation
Number of subjects: 155
Study 34006174 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-scan meditation
Number of subjects: 155
Study 34006174 — intervention group
Group type: EXPERIMENTAL
Intervention: High equanimity
Number of subjects: 155
Study 34006174 — intervention group
Group type: EXPERIMENTAL
Intervention: Low equanimity
Number of subjects: 155
Study 34006174 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 155
Study 34255745 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg in week 1, 1000 mg in week 2, 2000 mg daily for weeks 3-12)
Number of subjects: 23
Study 34255745 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 23
Study 32511207 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline-air hysterosalpingo-contrast sonography (SA-HyCoSy)
Number of subjects: 19
Study 32511207 — intervention group
Group type: COMPARATOR
Intervention: Modified hysterosalpingogram (mHSG)
Number of subjects: 19
Study 35649699 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum neurofilament light chain (sNfL) levels during periods of active inflammation (Gd+ lesions present or recently present)
Number of subjects: 85
Study 35649699 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean sNfL levels during periods of remission (no Gd+ lesions present or recently present)
Number of subjects: 85
Study 33541306 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) of propofol anesthesia
Number of subjects: 40
Study 33541306 — intervention group
Group type: COMPARATOR
Intervention: Manual infusion (MI) of propofol anesthesia
Number of subjects: 40
Study 32317100 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridaforolimus-eluting stents (RES)
Number of subjects: 1914
Study 32317100 — intervention group
Group type: COMPARATOR
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 1914
Study 33454272 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily for 6 months
Number of subjects: 97
Study 33454272 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 97
Study 32000731 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodule spiculation
Number of subjects: 152
Study 32000731 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger nodule size
Number of subjects: 152
Study 32000731 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation with haemoptysis
Number of subjects: 152
Study 32000731 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation with weight loss
Number of subjects: 152
Study 32000731 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation for urgent review by the reporting radiologist
Number of subjects: 152
Study 32000731 — intervention group
Group type: EXPERIMENTAL
Intervention: Female GP gender
Number of subjects: 152
Study 32000731 — intervention group
Group type: COMPARATOR
Intervention: Haemoptysis with a normal chest CT scan
Number of subjects: 152
Study 32000731 — intervention group
Group type: COMPARATOR
Intervention: Isolated mediastinal lymphadenopathy
Number of subjects: 152
Study 35635652 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib dose-escalation therapy starting at 80 mg/day, escalating to 120 mg/day in Week 2 and 160 mg/day in Week 3 if no severe toxicities observed.
Number of subjects: 57
Study 35635652 — intervention group
Group type: COMPARATOR
Intervention: Regorafenib standard therapy (implied as a comparison).
Number of subjects: 57
Study 35381742 — intervention group
Group type: EXPERIMENTAL
Intervention: MUC1-GEM-PBCA-NP
Number of subjects: 0
Study 32671481 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab co-administered with vitamin D (≥ 400 IU/day) and Ca (≥ 600 mg/day)
Number of subjects: 956
Study 32671481 — intervention group
Group type: COMPARATOR
Intervention: Placebo co-administered with vitamin D (≥ 400 IU/day) and Ca (≥ 600 mg/day)
Number of subjects: 956
Study 35507499 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablation plus ICD
Number of subjects: 121
Study 35507499 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy plus ICD
Number of subjects: 121
Study 34658253 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion to mimic prandial insulin response (full dose, 80% dose, 60% dose)
Number of subjects: 54
Study 34658253 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon infusion at 0.65 ng/kg/min (nonsuppressed day)
Number of subjects: 54
Study 34658253 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon infusion at 0.65 ng/kg/min (suppressed day)
Number of subjects: 54
Study 34658253 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate regression analysis adjusted for age, sex, weight, and insulin dose
Number of subjects: 54
Study 33836922 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage diagnostic classification system using an extremely randomized trees machine learning algorithm.
Number of subjects: 73
Study 32973120 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest SES tertile
Number of subjects: 525
Study 32973120 — intervention group
Group type: COMPARATOR
Intervention: Quality of life
Number of subjects: 525
Study 34954718 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly HIV self-testing and quarterly in-clinic testing
Number of subjects: 110
Study 34954718 — intervention group
Group type: COMPARATOR
Intervention: Quarterly in-clinic HIV testing alone (standard of care)
Number of subjects: 110
Study 32533548 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) for eight sessions
Number of subjects: 50
Study 32533548 — intervention group
Group type: COMPARATOR
Intervention: Conventional medications and psycho-education (control group)
Number of subjects: 50
Study 35383832 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily and Aspirin 100 mg once daily
Number of subjects: 12964
Study 32615579 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow’s milk-based infant formula with added prebiotic blend (PDX/GOS)
Number of subjects: 161
Study 32615579 — intervention group
Group type: COMPARATOR
Intervention: Cow’s milk-based infant formula (Control)
Number of subjects: 161
Study 32704380 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraception Choices website (n = 464)
Number of subjects: 927
Study 32704380 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (n = 463)
Number of subjects: 927
Study 36244667 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX, 0.6 μg/kg)
Number of subjects: 96
Study 36244667 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DEX)
Number of subjects: 96
Study 33557798 — intervention group
Group type: EXPERIMENTAL
Intervention: Female veterans
Number of subjects: 85
Study 33612197 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 160
Study 33612197 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral self-control therapy (BSCT)
Number of subjects: 160
Study 33612197 — intervention group
Group type: COMPARATOR
Intervention: Brief advice (BA)
Number of subjects: 160
Study 32150255 — intervention group
Group type: EXPERIMENTAL
Intervention: NKTR-181 (oxycodegol)
Number of subjects: 610
Study 32150255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 610
Study 34724084 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual nutritional counseling every 2 weeks during therapy
Number of subjects: 46
Study 34724084 — intervention group
Group type: COMPARATOR
Intervention: No nutritional counseling (control group)
Number of subjects: 46
Study 34312935 — intervention group
Group type: COMPARATOR
Intervention: MDDS (short disease duration)
Number of subjects: 45
Study 34312935 — intervention group
Group type: COMPARATOR
Intervention: MDDL (long disease duration)
Number of subjects: 45
Study 34312935 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analyses
Number of subjects: 45
Study 32218561 — intervention group
Group type: EXPERIMENTAL
Intervention: Consultation with General Practitioners (GPs) for NSLBP
Number of subjects: 115
Study 32218561 — intervention group
Group type: EXPERIMENTAL
Intervention: LBP episode of less than 12 weeks
Number of subjects: 115
Study 32218561 — intervention group
Group type: EXPERIMENTAL
Intervention: Maladaptive psychosocial factors
Number of subjects: 115
Study 32218561 — intervention group
Group type: EXPERIMENTAL
Intervention: Employment status
Number of subjects: 115
Study 35152574 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoshen Qianyang acupuncture
Number of subjects: 120
Study 35152574 — intervention group
Group type: COMPARATOR
Intervention: Xingnao Kaiqiao acupuncture (Control)
Number of subjects: 120
Study 34774334 — intervention group
Group type: EXPERIMENTAL
Intervention: Etelcalcetide (5 mg per dose intravenously)
Number of subjects: 33
Study 34774334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 36397435 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC D-blade videolaryngoscope
Number of subjects: 90
Study 36397435 — intervention group
Group type: COMPARATOR
Intervention: McCoy laryngoscope
Number of subjects: 90
Study 32483253 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Word Form Area (VWFA) activity during encoding
Number of subjects: 0
Study 32483253 — intervention group
Group type: COMPARATOR
Intervention: Induced high gamma power (iHGP) in posterior superior temporal gyrus (STGp)
Number of subjects: 0
Study 32483253 — intervention group
Group type: COMPARATOR
Intervention: Task performance
Number of subjects: 0
Study 33435287 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-feeding Continuous Energy Restriction (CER) - 25% daily energy restriction
Number of subjects: 30
Study 33435287 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-feeding Intermittent Energy Restriction (IER) - alternating ad libitum and 75% energy restriction days
Number of subjects: 30
Study 33435287 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 30
Study 33435287 — intervention group
Group type: COMPARATOR
Intervention: Both IER and CER
Number of subjects: 30
Study 35266148 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut oral immunotherapy (POIT) with AR101
Number of subjects: 0
Study 35266148 — intervention group
Group type: COMPARATOR
Intervention: Double-blinded placebo-controlled peanut challenge (DBPCFC)
Number of subjects: 0